Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|February 1, 2024
Efficacy and safety analysis of TACE + PEI + lenvatinib compared with TACE + lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective studyHaohao Lu, Chuansheng Zheng, Bin Liang, et al.
BMC Cancer|March 25, 2023
Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective studyHaohao Lu, Qing Ye, Chuansheng Zheng, et al.
BMC Cancer|May 16, 2025
RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinomaHaohao Lu, Ya Gao, Xiangwen Xia, et al.
Scientific Reports|October 17, 2025
The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgeryHaohao Lu, Bin Liang, Xiangwen Xia, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 20, 2013
Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) modelXiangwen Xia, Xin Li, Gansheng Feng, et al.
The British Journal of Radiology|November 11, 2021
Liver abscess after drug-eluting bead chemoembolization in patients with metastatic hepatic tumorsTianhe Ye, Peng Zhu, Zhiping Liu, et al.
Abdominal Radiology (New York)|December 10, 2021
Evaluation of dangerous collateral vessels and thrombus in Budd-Chiari syndrome patients with inferior vena cava obstructionDehan Liu, Qianqian Ren, Tianhe Ye, et al.
Fundamental & Clinical Pharmacology|August 18, 2019
NRF2/ABCB1-mediated efflux and PARP1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cellsXiangwen Xia, Qi Wang, Tianhe Ye, et al.
Cancer Cell International|April 1, 2020
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancerQianqian Ren, Peng Zhu, Hui Zhang, et al.
European Journal of Radiology|March 23, 2023
Contrast-enhanced CT parameters predict short-term tumor response in patients with hepatocellular carcinoma who received sequential combined anti-angiogenesis and immune checkpoint inhibitor treatmentYiming Feng, Hui Zhang, Qianqian Ren, et al.
Pageof 4